Evidence map›Paper›PMID 32249102›Full record

ReviewResearch in social & administrative pharmacy : RSAP2021

Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.

Si-Qian Zheng, Li Yang, Peng-Xiang Zhou, Hui-Bo Li, Fang Liu, Rong-Sheng Zhao

Open access · greenAbstract readReview
In one paragraph

Review in Research in social & administrative pharmacy : RSAP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 1 pooled it
35.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 1 synthesis or guideline pooled it, 342 citations in OpenAlex.

  1. Pooled it
  2. Role of HWorld journal of clinical cases · 2022
    Trial
  3. Review
  4. Article
  5. Community pharmacy resiliency during Covid-19 pandemic in Iran: A qualitative study.Exploratory research in clinical and social pharmacy · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Si-Qian ZhengDepartment of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
Li YangDepartment of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
Peng-Xiang ZhouDepartment of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
Hui-Bo LiDepartment of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
Fang LiuDepartment of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
Rong-Sheng ZhaoDepartment of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China. Electronic address: zhaorongsheng@bjmu.edu.cn.
Peking University · CNPeking University Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic.

objectiveTo discuss community pharmacists' role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population.

methodCollect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients' PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic.

resultsCommunity pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic.

conclusionPC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients' need. Community pharmacies shall work as a strong supporter of patient's medication and protective equipment supply. Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control.

Indexed as

ChinaCommunity Pharmacy ServicesCOVID-19Health Services Needs and DemandHumansPersonal Protective EquipmentPharmacistsProfessional RoleCommunity pharmacyCOVID-19Novel coronavirus pneumoniaPharmaceutical careSafe medication use

Identifiers

PMID32249102
PMCPMC7102520
OpenAlexW3012789704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.